NFL Biosciences (XPAR:ALNFL) Pre-Tax Income : €-4.11 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is NFL Biosciences Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. NFL Biosciences's pretax income for the six months ended in Dec. 2023 was €-1.80 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was €-4.11 Mil. NFL Biosciences's pretax margin was %.

NFL Biosciences Pre-Tax Income Historical Data

The historical data trend for NFL Biosciences's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NFL Biosciences Pre-Tax Income Chart

NFL Biosciences Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

-0.35

-0.31

-1.12

-2.86

-4.11

NFL Biosciences Semi-Annual Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial			-	-0.95	-1.91	-2.31	-1.80

Competitive Comparison of NFL Biosciences's Pre-Tax Income

For the Biotechnology subindustry, NFL Biosciences's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NFL Biosciences's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NFL Biosciences's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where NFL Biosciences's Pre-Tax Income falls into.

NFL Biosciences Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

NFL Biosciences's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-4.2	+	0	+	-0.007	+	0.095	+	0
	=	-4.11

NFL Biosciences's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-1.857	+	0	+	-0.006	+	0.063	+	-0.00099999999999989
	=	-1.80

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-4.11 Mil.

NFL Biosciences (XPAR:ALNFL) Pre-Tax Income Explanation

NFL Biosciences's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-1.801	/	0
	=	%

NFL Biosciences Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of NFL Biosciences's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

NFL Biosciences (XPAR:ALNFL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NFL Biosciences SA (XPAR:ALNFL) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

82F:Germany

Address

199 rue Helene Boucher, Castelnau-le-Lez, FRA, 34170

Website

https://www.nflbiosciences.com/

NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.

NFL Biosciences (XPAR:ALNFL) Headlines

No Headlines